Viewing Study NCT05220605

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:30 AM
Ignite Modification Date: 2026-01-12 @ 8:41 AM
Study NCT ID: NCT05220605
Status: COMPLETED
Last Update Posted: 2022-09-15
First Post: 2022-01-24
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Nebulised BromAc in Healthy Volunteers
Sponsor: Mucpharm Pty Ltd
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None COVID-19 Pneumonia View
None Bromelains Adverse Reaction View
None Acetylcysteine Adverse Reaction View
None Mucus; Plug View
None COVID-19 Acute Respiratory Distress Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None bromelain View
None BromAc View
None acetylcysteine View
None SARS-CoV-2 View
None mucin View
None mucus plug View
None COVID-19 pneumonia View
None ventilator associated pneumonia View
None secondary bacterial infection View